Vyoma Shinde, OD
Optometry · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 3 carriers
- Office
- 1
Offices
1 location · Amplify Physicians of California PC · 4 clinicians in this group
Plans that list them
7 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shinde’s office at (408) 739-6200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence A35466 · Cancelled
Licence status: Cancelled · since 1980 · National Autonomous University of Mexico Faculty of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$10,949
Medicare paid this office $10,949 for 94 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 50 | $4,687 | $87 |
| Established patient problem focused exam of visual system | 38 | $3,327 | $71 |
| New patient complete exam of visual system | 13 | $1,338 | $103 |
Who their Medicare patients are
94 Original Medicare patients in 2024. Average age 77 · Women 61% · Also on Medicaid 27% · Health risk score 1.09. Above the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 75% · Diabetes 46% · Coronary heart disease 32% · Chronic kidney disease 26% · Depression 20% · Heart failure 17% · Cancer 16% · Atrial fibrillation 16%.
The office billed $22,457, Medicare allowed $15,667 and paid $10,949; for 150 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$85,945 in 2024
Medicaid paid $85,945 for 2,878 billed services this clinician did in 2024, up to 99 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 465 | $82,354 |
| Frames, purchases | 331 | $1,020 |
| INTRM OPH EXAM NEW PATIENT | 486 | $907 |
| Fitting of monofocal spectacles | 255 | $741 |
| DETERMINATION REFRACTIVE STATE | 819 | $669 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 253 | $216 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $38 |
| TOBACCO NON-USER | 120 | $0 |
| Medication list documented in medical record (COA) | 16 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 16 | $0 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 82 | $0 |
| Fitting of bifocal spectacles | 22 | $0 |
| 2024 | 2,878 | 12 | 99 | $85,945 |
| 2023 | 515 | 9 | 35 | $17,536 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 100 | $17,536 |
| TOBACCO NON-USER | 21 | $0 |
| Medication list documented in medical record (COA) | 48 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 48 | $0 |
| INTRM OPH EXAM NEW PATIENT | 95 | $0 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 12 | $0 |
| DETERMINATION REFRACTIVE STATE | 122 | $0 |
| Fitting of monofocal spectacles | 32 | $0 |
| Frames, purchases | 37 | $0 |
Drugs they prescribed that Part D paid
$228,454
Pharmacies billed $228,454 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 111) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
73 generic and 38 brand-name prescriptions · $228,454 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Latanoprost | 13 | $386 | $9 |
| Azelastine | 12 | $260 | $12 |
Year by year
| 2024 | 111 | 43 | 0% (0) | 34% | $228,454 |
| 2023 | 14 | 11 | 0% (0) | None | $1,533 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$1,320 in 2025
| 2025 | 7 | 34 | None | $1,320 |
| 2024 | 6 | 10 | None | $548 |
| 2023 | 1 | 1 | None | $101 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotissue Holdings | None | $341 | 5 payments
|
| Dompe US | Oxervate | $252 | 5 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $211 | 16 payments
|
| Glaukos | Photrexa Viscous and Photrexa | $182 | 1 payment
|
| Alcon Vision | Tryptyr | $179 | 4 payments
|
| Bausch & Lomb Americas | Alden Scleral Zenlens | $135 | 2 payments
|
See all 34 published payments
| Dompe US | Meals · 2025-11-10 | Oxervate | $33 |
| Tarsus Pharmaceuticals | Meals · 2025-11-06 | Xdemvy | $6 |
| Alcon Vision | Meals · 2025-11-04 | Tryptyr | $15 |
| Tarsus Pharmaceuticals | Meals · 2025-10-28 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-10-22 | Xdemvy | $7 |
| Tarsus Pharmaceuticals | Meals · 2025-10-06 | Xdemvy | $121 |
| Biotissue Holdings | Meals · 2025-09-17 | None | $100 |
| Tarsus Pharmaceuticals | Meals · 2025-09-11 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-09-02 | Xdemvy | $6 |
| Oyster Point Pharma | Meals · 2025-08-27 | Tyrvaya | $20 |
| Alcon Vision | Meals · 2025-08-21 | Tryptyr | $126 |
| Tarsus Pharmaceuticals | Meals · 2025-08-20 | Xdemvy | $6 |
| Dompe US | Meals · 2025-08-20 | Oxervate | $55 |
| Bausch & Lomb Americas | Meals · 2025-08-13 | Alden Corneal Gp | $34 |
| Glaukos | Meals · 2025-08-05 | Photrexa Viscous and Photrexa | $182 |
| Tarsus Pharmaceuticals | Meals · 2025-07-23 | Xdemvy | $6 |
| Biotissue Holdings | Meals · 2025-07-18 | None | $76 |
| Bausch & Lomb Americas | Meals · 2025-07-17 | Alden Scleral Zenlens | $101 |
| Tarsus Pharmaceuticals | Meals · 2025-07-10 | Xdemvy | $6 |
| Alcon Vision | Meals · 2025-07-08 | Eysuvis | $26 |
| Dompe US | Meals · 2025-07-03 | Oxervate | $7 |
| Tarsus Pharmaceuticals | Meals · 2025-06-25 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-06-19 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-06-05 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-05-29 | Xdemvy | $6 |
| Biotissue Holdings | Meals · 2025-05-26 | None | $23 |
| Tarsus Pharmaceuticals | Meals · 2025-05-13 | Xdemvy | $6 |
| Dompe US | Meals · 2025-05-08 | Oxervate | $125 |
| Tarsus Pharmaceuticals | Meals · 2025-04-28 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-04-15 | Xdemvy | $7 |
| Biotissue Holdings | Meals · 2025-04-08 | None | $89 |
| Biotissue Holdings | Meals · 2025-03-27 | None | $52 |
| Alcon Vision | Meals · 2025-03-04 | Precision7 | $12 |
| Dompe US | Meals · 2025-02-18 | Oxervate | $32 |
See earlier years (2024, 2023)
2024: $548
| Visioneering Technologies | None | $190 | 1 payment
|
| CooperVision | Paragon Crt | $141 | 3 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $112 | 2 payments
|
| Dompe US | Oxervate | $58 | 2 payments
|
| Biotissue Holdings | None | $25 | 1 payment
|
| Bausch & Lomb Americas | Miebo | $22 | 1 payment
|
2023: $101
| Bausch & Lomb Americas | Miebo | $101 | 1 payment
|
Professional record
- NPI
- 1659064335
- Licence
- CA 35466California A35466: Cancelled
- Trained
- University of California - School of Optometry, 2023
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X); Federal specialty code 152WC0802X (152WC0802X); Federal specialty code 152WL0500X (152WL0500X); Federal specialty code 152WP0200X (152WP0200X); Federal specialty code 152WS0006X (152WS0006X); Federal specialty code 152WV0400X (152WV0400X); Federal specialty code 152WX0102X (152WX0102X)
- Mailing address
- 633 Hidden Lakes Dr, Martinez, CA, 94553
- NPI first listed
- 2023-05-30
- NPI last updated
- 2024-10-28
- NPI record certified
- 2024-10-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2369 Ocean Ave Ste 3, San Francisco, CA, 94127